Under the terms of the collaborative agreement, VaxyGen and Georgia State University will work in the commercial development of the resident know-how and technology. VaxyGen provides custom contract
The patent, ‘Modified anticholinergic neurotoxins as modulators of the autoimmune reaction’ describes a composition of matter and method of its use to treat multiple sclerosis in humans. The
Under the terms of the partnership, Bend Research clients will have access to Hovione’s commercial-scale pharmaceutical manufacturing facilities and give Hovione clients access to Bend Research’s oral drug-delivery,
As per the contract, SAIC will provide product development services either directly or through management of subcontractors in areas including assay development, cGMP manufacture, feasibility assessments, process development,
Anticalins are novel, next generation therapeutic proteins designed to bind and antagonize a wide spectrum of ligands. They derived from human lipocalins, designed to solve the pharmacological and
The companies will complete the preclinical testing of SKL-PSY within two years with an Investigational New Drug (IND) application filing in China by Medicilon and in the US
BYETTA is a glucagon-like peptide-1 (GLP-1) receptor agonist which shows similar effects as the human incretin hormone GLP-1, according to Eli Lilly and Company . A study conducted
The product will be sold and distributed by Founder Pharma in China. Perrigo chairman and CEO Joseph C Papa said Synthetic’s strong brand, marketing, and distribution would help
Internal investigations revealed the presence of a microbial contaminant that exceeds the product specifications which may subsequently result in a subpar product. The product bearing the UPC Code,
Exparel is a long-acting bupivacaine which combines product delivery technology, DepoFoam and is an anesthetic/analgesic. The data has been pooled from five active-control, double-blind, randomized, multicenter, parallel-group trials
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.